1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Sports Talk

Here's a place to hang out and chat about sports with your fellow reps.


Sort By:
Title
Replies Views
Last Message ↓
  1. BAMABOY
    Replies:
    2
    Views:
    123
  2. BAMABOY
    Replies:
    11
    Views:
    311
  3. Vagitarian
    Replies:
    0
    Views:
    45
  4. BAMABOY
    Replies:
    8
    Views:
    271
  5. BAMABOY
    Replies:
    9
    Views:
    282
  6. BAMABOY
    Replies:
    11
    Views:
    353
  7. BAMABOY
    Replies:
    7
    Views:
    300
  8. BAMABOY
    Replies:
    10
    Views:
    341
  9. BAMABOY
    Replies:
    10
    Views:
    395
  10. BAMABOY
    Replies:
    9
    Views:
    431
  11. BAMABOY
    Replies:
    18
    Views:
    399
  12. BAMABOY
    Replies:
    12
    Views:
    428
  13. BAMABOY
    Replies:
    13
    Views:
    396
  14. BAMABOY
    Replies:
    11
    Views:
    405
  15. BAMABOY
    Replies:
    15
    Views:
    452
  16. BAMABOY
    Replies:
    9
    Views:
    549
  17. BAMABOY
    Replies:
    13
    Views:
    528
  18. Drug Dumper
    Replies:
    1
    Views:
    538
  19. BAMABOY
    Replies:
    18
    Views:
    1,230
  20. BAMABOY
    Replies:
    6
    Views:
    517

Thread Display Options

Loading...